Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Marquez-Rodas, I; Lobo, M; Flores-Sanchez, C; Sanz, M; Luque, S; Lizarraga, S; Gonzalez-Asanza, C; Pajares, JA; Peligros, MI; Bueno, O; Mata, C; Lopez, C; Lopez-Tarruella, S; Jerez, Y; Munoz-Martin, A; Blanco, M; Die-Trill, M; Justel, JP; Solera, J; Martin, M.

Five Years of Multidisciplinary Care in Hereditary Cancer: Our Experience in a Spanish University Hospital

ONCOLOGY. 2017; 92(2): 68-74 Nº de citas: 3 [doi:10.1159/000452280]

Cabrero, M; Martin, A; Briones, J; Gayoso, J; Jarque, I; Lopez, J; Grande, C; Heras, I; Arranz, R; Bernal, T; Perez-Lopez, E; Lopez-Godino, O; Conde, E; Caballero, D.

Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2017; 23(1): 53-59 Nº de citas: 10 [doi:10.1016/j.bbmt.2016.10.003]

Martinez, C; Jorge, AS; Pereira, A; Moreno, M; Nunez, J; Gayoso, J; Gonzalez-Medina, J; Revilla, N; Sampol, A; Domingo-Domenech, E; de la Cruz, F; Morales, A; Rodriguez-Salazar, M; Valiente, S; Perez-Ceballos, E; de Oteyza, JP; Garcia-Sanz, R.

Comorbidities, not age, are predictive of survival after autologous hematopoietic cell transplantation for relapsed/refractory Hodgkin's lymphoma in patients older than 50 years

ANNALS OF HEMATOLOGY. 2017; 96(1): 9-16 Nº de citas: 15 [doi:10.1007/s00277-016-2832-6]

Cela, E; Velez, AG; Aguado, A; Medin, G; Bellon, JM; Belendez, C.

Chronic brain damage in sickle cell disease and its relation with quality of life

MEDICINA CLINICA. 2016; 147(12): 531-536 Nº de citas: 5 [doi:10.1016/j.medcli.2016.07.028]

Blanco, G; Puiggros, A; Baliakas, P; Athanasiadou, A; Garcia-Malo, M; Collado, R; Xochelli, A; Rodriguez-Rivera, M; Ortega, M; Calasanz, MJ; Luno, E; Vargas, M; Grau, J; Martinez-Laperche, C; Valiente, A; Cervera, J; Anagnostopoulos, A; Gimeno, E; Abella, E; Stalika, E; Hernandez-Rivas, JM; Ortuno, FJ; Robles, D; Ferrer, A; Ivars, D; Gonzalez, M; Bosch, F; Abrisqueta, P; Stamatopoulos, K; Espinet, B.

Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations

Oncotarget. 2016; 7(49): 80916-80924 Nº de citas: 25 [doi:10.18632/oncotarget.13106]

Ruiz Labarta, F. J.; Pintado Recarte, M. P.; Alvarez Luque, A.; Joigneau Prieto, L.; Perez Martin, L.; Gonzalez Leyte, M.; Palacio Abizanda, F.; Morillas Ramirez, F.; Perez Corral, A.; Ortiz Quintana, L.; De Leon-Luis, J..

Outcomes of pelvic arterial embolization in the management of postpartum haemorrhage: a case series study and systematic review

European Journal of Obstetrics & Gynecology and Reproductive Biology. 2016; 206: 12-21 Nº de citas: 28 [doi:10.1016/j.ejogrb.2016.07.510]

Gayoso, J; Balsalobre, P; Pascual, MJ; Castilla-Llorente, C; Lopez-Corral, L; Kwon, M; Serrano, D; Pinana, JL; Herrera, P; Ferra, C; Pascual, C; Heras, I; Montesinos, P; Zabalza, A; Bento, L; Figuera, A; Buno, I; Diez-Martin, JL.

Busulfan-based reduced intensity conditioning regimens for haploidentical transplantation in relapsed/refractory Hodgkin lymphoma: Spanish multicenter experience

BONE MARROW TRANSPLANTATION. 2016; 51(10): 1307-1312 Nº de citas: 26 [doi:10.1038/bmt.2016.115]

Gonzalez-Lopez, TJ; Alvarez-Roman, MT; Pascual, C; Sanchez-Gonzalez, B; Fernandez-Fuentes, F; Jarque, I; Perez-Rus, G; Perez-Crespo, S; Bernat, S; Hernandez-Rivas, JA; Andrade, MM; Cortes, M; Gomez-Nunez, M; Olivera, P; Martinez-Robles, V; Fernandez-Rodriguez, A; Fuertes-Palacio, MA; Fernandez-Minano, C; de Cabo, E; Fisac, R; Aguilar, C; Barez, A; Penarrubia, MJ; Garcia-Frade, LJ; Gonzalez-Porras, JR.

Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice

EUROPEAN JOURNAL OF HAEMATOLOGY. 2016; 97(3): 297-302 Nº de citas: 35 [doi:10.1111/ejh.12725]

Osorio, S; Casado, LF; Giraldo, P; Maestro, B; Andrade, M; Redondo, S; Garcia-Gutierrez, V; Ayala, R; Garcia, N; Steegmann, JL.

Chronic myeloid leukaemia in Spain: Its presentation characteristics have changed. Spanish section of the EUTOS population-based registry

REVISTA CLINICA ESPANOLA. 2016; 216(6): 293-300 Nº de citas: 5 [doi:10.1016/j.rce.2016.03.001]

Proserpio, T; Veneroni, L; Silva, M; Lassaletta, A; Lorenzo, R; Magni, C; Bertolotti, M; Barisone, E; Mascarin, M; Jankovic, M; D'Angelo, P; Clerici, CA; Garrido-Colino, C; Gutierrez-Carrasco, I; Echebarria, A; Biondi, A; Massimino, M; Casale, F; Tamburini, A; Ferrari, A.

Spiritual support for adolescent cancer patients: a survey of pediatric oncology centers in Italy and Spain

TUMORI JOURNAL. 2016; 102(4): 376-380 Nº de citas: 13 [doi:10.5301/tj.5000494]

De La Serna, J; Sanz, J; Bermudez, A; Cabrero, M; Serrano, D; Vallejo, C; Gomez, V; Moraleda, JM; Perez, SG; Caballero, MD; Conde, E; Lahuerta, JJ; Sanz, G.

Toxicity and efficacy of busulfan and fludarabine myeloablative conditioning for HLA-identical sibling allogeneic hematopoietic cell transplantation in AML and MDS

BONE MARROW TRANSPLANTATION. 2016; 51(7): 961-966 Nº de citas: 13 [doi:10.1038/bmt.2016.42]

Bautista, F; Gallego, S; Canete, A; Mora, J; Heredia, CD; Cruz, O; Fernandez, JM; Rives, S; Madero, L; Castel, V; Cela, ME; Ramirez, G; Sabado, C; Acha, T; Astigarraga, I; Sastre, A; Munoz, A; Guibelalde, M; Moreno, L.

Landscape of early clinical trials for childhood and adolescence cancer in Spain

Clinical & Translational Oncology. 2016; 18(7): 708-713 Nº de citas: 6 [doi:10.1007/s12094-015-1421-9]

Paiva, B; Cedena, MT; Puig, N; Arana, P; Vidriales, MB; Cordon, L; Flores-Montero, J; Gutierrez, NC; Martin-Ramos, ML; Martinez-Lopez, J; Ocio, EM; Hernandez, MT; Teruel, AI; Rosinol, L; Echeveste, MA; Martinez, R; Gironella, M; Oriol, A; Cabrera, C; Martin, J; Bargay, J; Encinas, C; Gonzalez, Y; Van Dongen, JJM; Orfao, A; Blade, J; Mateos, MV; Lahuerta, JJ; San Miguel, JF.

Minimal residual disease monitoring and immune profiling in multiple myeloma in elderly patients

BLOOD. 2016; 127(25): 3165-3174 Nº de citas: 137 [doi:10.1182/blood-2016-03-705319]

Castilla-Rodriguez, I; Cela, E; Vallejo-Torres, L; Valcarcel-Nazco, C; Dulin, E; Espada, M; Rausell, D; Mar, J; Serrano-Aguilar, P.

Cost-effectiveness analysis of newborn screening for sickle-cell disease in Spain

Expert Opinion on Orphan Drugs. 2016; 4(6): 567-575 Nº de citas: 11 [doi:10.1080/21678707.2016.1179572]

Bastos-Oreiro, M; Anguita, J; Martinez-Laperche, C; Fernandez, L; Buces, E; Navarro, A; Pascual, C; Perez-Corral, A; Balsalobre, P; Munoz, C; Kwon, M; Serrano, D; Perez-Martinez, A; Buno, I; Gayoso, J; Diez-Martin, JL.

Inhibitory killer cell immunoglobulin-like receptor (iKIR) mismatches improve survival after T-cell-repleted haploidentical transplantation

EUROPEAN JOURNAL OF HAEMATOLOGY. 2016; 96(5): 483-491 Nº de citas: 17 [doi:10.1111/ejh.12616]

Penalver, FJ; Delgado, J; Loscertales, J; Sastre, JL; Pena, A; Olave, MT; Osorio, S; de la Fuente, A; Salar, A; Grande, C; Ceballos, EP; Deben, G; Echeveste, A; Casado, F; de la Rubia, J; Lahuerta, JJ; Mateos, MV.

Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myeloma

EUROPEAN JOURNAL OF HAEMATOLOGY. 2016; 96(5): 532-540 Nº de citas: 2 [doi:10.1111/ejh.12633]

de la Fuente-Gonzalo, F; Nieto, JM; Velasco, D; Cela, E; Perez, G; Fernandez-Teijeiro, A; Escudero, A; Villegas, A; Gonzalez-Fernandez, FA; Ropero, P.

HB Puerta del Sol [HBA1: c. 148A > C], HB Valdecilla [HBA2: c. 3G > T], HB Gran Via [HBA2: c. 98T > G], HB Macarena [HBA2: c. 358C > T] and HB El Retiro [HBA2: c. 364_366dupGTG]: description of five new hemoglobinopathies

CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2016; 54(4): 553-560 Nº de citas: 6 [doi:10.1515/cclm-2015-0649]

Yazer, MH; Lozano, M; Crighton, G; Greenway, A; Comande, M; Savoia, H; Wood, E; Gilli, S; Castilho, L; Saad, STO; Galacteros, F; Noizat-Pirenne, F; Pazgal, I; Stark, P; Orlin, Y; Perseghin, P; Masera, N; Cela, E; Anguita, J; Wikman, A; Delaney, M.

Transfusion service management of sickle-cell disease patients

VOX SANGUINIS. 2016; 110(3): 288 Nº de citas: 6 [doi:10.1111/vox.12296]